679 Characterization of tumor specific CD8+ T cell responses in patients with recurrent/metastatic HPV16-positive head and neck cancer receiving HB-200 monotherapy as second or later line treatment in a phase 1 study

Autor: Siqing Fu, Rom S Leidner, Ki Chung, Jiaxin Niu, Ilian Tchakov, Debra L Richardson, Xiaoping Qing, Jorge Nieva, Douglas Adkins, Alan L Ho, Minh Phan, Alexander T Pearson, Marshall R Posner, Lisle Nabell, Stuart Wong, Katerin Rojas, Ari J Rosenberg, Trisha Kaufmann, Christopher Plescia, Corinne Iacobucci, Kia Katchar, Klaus Orlinger, Katia Schlienger, David G Pfister

Publikováno v: Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)

Externí odkaz: https://doaj.org/article/2139506c3af64695acf470195ba8dd75

Abstract 3284: HB-201 and HB-202, an arenavirus-based immunotherapy, induces tumor T cell infiltration in patients with HNSCC and other HPV16+ tumors

Autor: Donna Edwards, Michael Schwendinger, Kia Katchar, Katia Schlienger, Klaus Orlinger, Igor Matushansky, Henning Lauterbach

Publikováno v: Cancer Research. 82:3284-3284

Background: Human Papillomavirus 16 (HPV16) is the most common etiologic agent of HPV-associated cancers. Treatment options are limited for patients with HPV16+ recurrent or metastatic cancers. HPV16 E7 and E6 oncogenes constitute attractive immunoth

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6960f3d357efcb1b1c4d736a76afe9de
https://doi.org/10.1158/1538-7445.am2022-3284

961MO Safety, efficacy, immunogenicity of arenavirus-based vectors HB-201 and HB-202 in patients with HPV16+ cancers

Autor: Alan Loh Ho, Katia Schlienger, Douglas Adkins, Ding Wang, Siquing Fu, Jorge Nieva, Marshall R. Posner, Ki Y Chung, Kia Katchar, L Nabell, Igor Matushansky, Jiaxin Niu, Alexander T. Pearson, C Lacobucci, Rom Leidner, D L Richardson, Xiaoping Qing, Stuart J. Wong, Agustin Pimentel, David G. Pfister

Publikováno v: Annals of Oncology. 32:S831-S832

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::39863ec2a15a14c449d7512376231e85
https://doi.org/10.1016/j.annonc.2021.08.1346

1527P Assessing clinical benefit of olaparib maintenance treatment in subgroups of patients with germline BRCA mutation (gBRCAm) and metastatic pancreatic cancer: Phase III POLO trial

Autor: Daniel Hochhauser, Anke Reinacher-Schick, Eileen M. O'Reilly, D-Y. Oh, Katia Schlienger, Michele Reni, J.O. Park, Dirk Arnold, Michael J. Hall, Talia Golan, Karen Cui, Teresa Macarulla, Gershon Y. Locker, Hedy L. Kindler, Pascal Hammel, Giampaolo Tortora, David McGuinness, E. Van Cutsem, Hana Algül

Publikováno v: Annals of Oncology. 31:S940-S941

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::103feb0f1709b8578479612d4be1a96e
https://doi.org/10.1016/j.annonc.2020.08.2010

Maintenance olaparib for germline BRCA-mutated metastatic pancreatic cancer

Autor: Hana Algül, Anke Reinacher-Schick, Katia Schlienger, David McGuinness, Teresa Macarulla, Eric Van Cutsem, Talia Golan, Giampaolo Tortora, Gershon Y. Locker, Pascal Hammel, Daniel Hochhauser, Karen Y. Cui, Do Youn Oh, Michael J. Hall, Michele Reni, Hedy L. Kindler, Joon Oh Park, Dirk Arnold, Eileen M. O'Reilly

Publikováno v: Scientia
Recercat. Dipósit de la Recerca de Catalunya
instname
Recercat: Dipósit de la Recerca de Catalunya
Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)

Actividad antitumoral; Calidad de vida con cáncer; PARP Activitat antitumoral; Qualitat de vida amb càncer; PARP Antitumor activity; Quality of life with cancer; PARP BACKGROUND Patients with a germline BRCA1 or BRCA2 mutation make up a small subgr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b64d853e6f7d1fdbed009f2e8888459d
http://hdl.handle.net/10807/155162